Day: December 3, 2025

HighlightsThe Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent for the FAK inhibitor narmafotinib The patent extends protection for narmafotinib to at least 2040Melbourne, Australia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces that it has received formal notification from the US Patent and Trademark Office (USPTO) that a key patent titled A salt and crystal form of a FAK Inhibitor has been granted. The Certificate of Grant follows on from the notification of allowance of the patent from the USPTO received in September1. This key patent protects the specific form of narmafotinib being developed clinically by the Company. The patent has already been granted in various important jurisdictions including...

Company flips from a $50 million stockholders’ deficit to $750K of positive equity MARLBOROUGH, Mass., Dec. 03, 2025 (GLOBE NEWSWIRE) — ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a constellation of technology-driven businesses powering the modern energy economy, today announced a current annual organic revenue run rate of $35 million, based on its existing operations and excluding revenue from its recently completed acquisitions of Amperics and Geo Impex. This compares to revenue of $22.7 million for the year ended December 31, 2024, an increase of approximately 54% on an annualized basis. After giving effect to the Amperics and Geo Impex acquisitions, the Company currently has positive stockholders’ equity of $750K, a sharp turnaround from a $50 million stockholders’ deficit following its de-SPAC...

KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (NASDAQ: BGLC) (“BGLC” or the “Company”), a biotechnology company advancing precision diagnostics and gene-based technologies, today announced the formal completion of its strategic transaction with Fidelion Diagnostics Pte. Ltd. (“Fidelion”) and Tongshu Biotechnology. With the closing of the agreements, BGLC has become a strategic shareholder in Fidelion Diagnostics and secured exclusive commercial rights for the VitaGuard™ Tumor-Naïve Minimal Residual Disease (MRD) liquid biopsy platform across Southeast Asia (ASEAN) — positioning the Company for long-term growth as precision oncology adoption accelerates across the region. Strategic Acquisition: 15% Equity Stake in Fidelion Diagnostics BGLC has acquired...

ROSEVILLE, Minn., Dec. 03, 2025 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of the assets of Redbird Chemical, Inc. (“Redbird”). Redbird distributes chemicals to its customers in eastern Texas within both the water treatment and industrial markets. “The acquisition of Redbird Chemical is important as we continue to expand in Texas, and we see opportunities to grow our Water Treatment business through the industrial base in that area. This tuck-in acquisition continues to demonstrate our ability to execute on our strategy to grow our business and accelerate our growth in the South,” said Hawkins Chief Executive Officer, Patrick H. Hawkins. Mr. Hawkins continued, “Redbird has built a strong business that is well-connected with the local...

RA’ANANA, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a strategic expansion of its core blood laboratory capabilities, marking a substantial step in the Company’s evolution into a broader cutting edge technologies, positioning it for accelerated future growth. The strategic expansion includes transitioning to a substantially larger, state-of-the-art laboratory facility, while planning to increase recruitment of specialized personnel, upgrading advanced research instrumentation, and expanding its operational capacity. The upgraded laboratory, expected to become fully operational within the coming weeks, is designed to support Inspira’s...

VISTA, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today announced the Company’s planned participation at the iAccess Alpha Virtual Best Ideas Winter Investment Conference to be held as a virtual event on December 9-10, 2025. Representing the Company, FLUX Power’s CEO, Krishna Vanka, and CFO Kevin Royal will deliver a company presentation at 4:00 PM ET on December 9, followed by one-on-one meetings with investors on December 10. iAccess Alpha hosts virtual investor conferences featuring companies recommended by investors. These two-day events include webcast presentations on Day 1, followed by one-on-one meetings between company management teams...

Event Scheduled for December 8, 2025 at 12:30 PM ET SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will be hosting a virtual analyst and investor event on Monday, December 8, 2025, at 12:30 PM ET / 9:30 AM PT, to discuss data on the triplet combination of ziftomenib (KOMZIFTI®) with venetoclax and azacitidine in newly diagnosed and relapsed/refractory acute myeloid leukemia scheduled for presentation at the 67th American Society of Hematology (ASH) Annual Meeting. The virtual event will feature members of the management team alongside lead investigators. The live webcast and replay will be available on the Company’s website at www.kuraoncology.com under the Investors...

New Agreement Solidifies Foothold in Southeast Asia and Highlights Compelling Global Cross-Selling Opportunities HUNTSVILLE, Ala., Dec. 03, 2025 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing for industry, healthcare, and first responders, today announced it has received an order from the Fire and Rescue Department of Malaysia for firefighter personal protective equipment. Terms of the order were not disclosed. The Fire and Rescue Department of Malaysia, commonly known as “Bomba”, is the federal agency of Malaysia responsible for firefighting and technical rescue with approximately 15,000 employees. Bomba safeguards lives and property across the nation and includes firefighters, experts in technical rescue, hazardous materials...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, Dec. 03, 2025 (GLOBE NEWSWIRE) — NioBay Metals Inc. (TSX-V: NBY) (“NioBay” or the “Corporation”), is pleased to announce that as a result of strong investor demand, the Company has increased the maximum gross proceeds of its previously announced “best efforts” private placement (the “Marketed Offering”) from C$5,000,000 to C$7,500,000. The upsized Marketed Offering is comprised of the sale of any combination of the following:units of the Corporation (each, a “Unit“) at a price of C$0.14 per Unit (the “Unit Price“), subject to the minimum sale of 7,142,858 Units for minimum gross proceeds of approximately C$1,000,000 from the sale of Units; flow-through units of the Corporation (each, a “FT...

Clinical utility data for Nodify Lung® tests to be presented at North American Conference on Lung Cancer (NACLC) highlighting potential for earlier diagnosis of lung cancer Development data for a new ultra-sensitive ESR1 assay for breast cancer treatment resistance monitoring to be presented at San Antonio Breast Cancer Symposium (SABCS) LOUISVILLE, Ky., Dec. 03, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces several poster presentations on lung cancer diagnostics and new research on breast cancer diagnostics at upcoming scientific meetings. At the 2025 North American Conference on Lung Cancer (NACLC), December 5 – 7, in Chicago, IL, Biodesix will present new findings on its on-market Nodify Lung® tests, with data that spotlight the importance of timely, accurate...